• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗阿瓦兹住院静脉吸毒者丙型肝炎病毒血清流行率研究(2001-2006 年)。

Seroprevalence study of HCV among hospitalized intravenous drug users in Ahvaz, Iran (2001-2006).

机构信息

Infectious Diseases and Tropical Medicine Research Center, Jundishapoor University of Medical Sciences, Ahvaz, Iran.

出版信息

J Infect Public Health. 2009;2(1):47-51. doi: 10.1016/j.jiph.2009.01.001. Epub 2009 Mar 6.

DOI:10.1016/j.jiph.2009.01.001
PMID:20701860
Abstract

BACKGROUND AND AIMS

Prevalence of hepatitis C virus (HCV) in intravenous drug users (IDU) varies in different areas according to socioeconomic and geographical circumstances. The present study was performed to determine seroprevalence of HCV in IDU individuals in Ahvaz, Iran.

MATERIALS AND METHODS

142 IDU patients were included in this retrospective study in Ahvaz southwest Iran from 2001 to 2006. Patients were placed in two groups determined by HCV Ab positive or negative status. Data were analyzed using SPSS for Windows (version 11.5; SPSS Inc., USA) software.

RESULTS

Out of total 142 cases, 74 persons (52.11%) had a positive HCV-Ab test according to the ELISA method. There was no difference in age, sex, level of education, residency and co-infection with HIV and hepatitis B virus between HCV-Ab positive (HAP) and HCV-Ab negative (HAN) groups (p>0.05). HCV-Ab positivity was significantly related to imprisonment and duration spent in prison [OR: 3.22, 95% (CI) 2.61-3.76, p<0.0001].

CONCLUSION

Patients with IDU constitute a high-risk group for acquisition of HCV infection. Transmission of HCV via sharing syringe and needle as well as blood transfusion has been a significant source of hepatitis C infection for patients with intravenous drug addiction.

摘要

背景与目的

根据社会经济和地理环境的不同,静脉吸毒者(IDU)中丙型肝炎病毒(HCV)的流行率在不同地区有所差异。本研究旨在确定伊朗阿瓦兹 IDU 个体中 HCV 的血清流行率。

材料与方法

本回顾性研究纳入了 2001 年至 2006 年期间来自伊朗西南部阿瓦兹的 142 名 IDU 患者。根据 HCV Ab 阳性或阴性状态将患者分为两组。使用 SPSS for Windows(版本 11.5;SPSS Inc.,美国)软件对数据进行分析。

结果

在总共 142 例中,根据 ELISA 方法,74 例(52.11%) HCV-Ab 检测呈阳性。HCV-Ab 阳性(HAP)和 HCV-Ab 阴性(HAN)组在年龄、性别、教育程度、居住地以及 HIV 和乙型肝炎病毒共感染方面无差异(p>0.05)。HCV-Ab 阳性与监禁和入狱时间显著相关[比值比:3.22,95%置信区间(CI):2.61-3.76,p<0.0001]。

结论

IDU 患者是感染 HCV 的高危人群。共用注射器和针头以及输血传播 HCV 是静脉吸毒成瘾患者丙型肝炎感染的重要来源。

相似文献

1
Seroprevalence study of HCV among hospitalized intravenous drug users in Ahvaz, Iran (2001-2006).伊朗阿瓦兹住院静脉吸毒者丙型肝炎病毒血清流行率研究(2001-2006 年)。
J Infect Public Health. 2009;2(1):47-51. doi: 10.1016/j.jiph.2009.01.001. Epub 2009 Mar 6.
2
Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.伦敦南部一个种族多样的HIV-1感染队列中丙型肝炎的患病率。
HIV Med. 2005 May;6(3):206-15. doi: 10.1111/j.1468-1293.2005.00291.x.
3
Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran.伊朗霍拉桑省比尔詹德地区男性吸毒囚犯中乙型和丙型肝炎的流行情况
Arch Iran Med. 2019 Sep 1;22(9):501-504.
4
HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.伊朗德黑兰注射吸毒者中的 HIV、丙型肝炎病毒和乙型肝炎病毒合并感染。
Int J Infect Dis. 2010 Jan;14(1):e28-33. doi: 10.1016/j.ijid.2009.03.002. Epub 2009 May 21.
5
The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.2017 年爱尔兰男性囚犯中未经治疗的慢性丙型肝炎病毒(HCV)感染的血清流行率及其相关危险因素:一项横断面研究。
Euro Surveill. 2019 Apr;24(14). doi: 10.2807/1560-7917.ES.2019.24.14.1800369.
6
Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.南澳大利亚囚犯中的丙型肝炎病毒感染:血清流行率、血清转化及危险因素。
Int J Infect Dis. 2009 Mar;13(2):201-8. doi: 10.1016/j.ijid.2008.06.011. Epub 2008 Sep 13.
7
Indications of immune protection from hepatitis C infection.丙型肝炎感染免疫保护的指征。
J Urban Health. 2004 Mar;81(1):58-60. doi: 10.1093/jurban/jth088.
8
Prevalence of selected sexually and blood-borne infections in Injecting drug abuser inmates of bandar abbas and roodan correction facilities, Iran, 2002.2002 年伊朗阿巴斯港和洛丹教养院注射吸毒者囚犯中某些性传播和血源传染病的流行情况。
Braz J Infect Dis. 2009 Oct;13(5):356-8. doi: 10.1590/S1413-86702009000500008.
9
Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.吉兰省吸毒囚犯丙型肝炎病毒感染率及危险因素
East Mediterr Health J. 2007 Mar-Apr;13(2):250-6.
10
Hepatitis C Seroprevalence Among HIV-Infected Childbearing Women in New York State in 2006.2006年纽约州感染艾滋病毒的育龄妇女丙型肝炎血清流行率
Matern Child Health J. 2016 Mar;20(3):550-5. doi: 10.1007/s10995-015-1853-4.

引用本文的文献

1
Hepatitis C Virus Coinfection in People With Human Immunodeficiency Virus in Iran: A Systematic Review and Meta-Analysis.伊朗人类免疫缺陷病毒感染者中的丙型肝炎病毒合并感染:一项系统评价和荟萃分析。
Open Forum Infect Dis. 2022 Sep 21;9(10):ofac477. doi: 10.1093/ofid/ofac477. eCollection 2022 Oct.
2
Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis.在三个选定的世卫组织东地中海区域国家中注射吸毒者中 HIV 和 HCV 的流行率:一项荟萃分析。
Harm Reduct J. 2021 May 27;18(1):59. doi: 10.1186/s12954-021-00505-4.
3
Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis.
伊朗减少伤害项目与注射吸毒者丙型肝炎流行率:一项更新的系统评价和累积荟萃分析。
Harm Reduct J. 2021 Jan 22;18(1):12. doi: 10.1186/s12954-020-00441-9.
4
The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa.中东和北非地区静脉注射吸毒人群中丙型肝炎病毒感染状况。
Addiction. 2020 Jul;115(7):1244-1262. doi: 10.1111/add.14944. Epub 2020 Feb 3.
5
A systematic review and meta-analysis of the prevalence of hepatitis C virus infection in people who inject drugs in Iran.伊朗注射吸毒人群丙型肝炎病毒感染率的系统评价和荟萃分析。
BMC Public Health. 2020 Jan 14;20(1):62. doi: 10.1186/s12889-020-8175-1.
6
Prevalence of HIV, Hepatitis B and C Virus Co-infections among Iranian High-Risk Groups: A Systematic Review and Meta-Analysis.伊朗高危人群中艾滋病毒、乙型肝炎和丙型肝炎病毒合并感染的患病率:系统评价和荟萃分析
Malays J Med Sci. 2019 May;26(3):37-48. doi: 10.21315/mjms2019.26.3.3. Epub 2019 Jun 28.
7
The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses.伊朗丙型肝炎病毒的流行病学:系统评价和荟萃分析。
Sci Rep. 2018 Jan 9;8(1):150. doi: 10.1038/s41598-017-18296-9.
8
Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa.利用丙型肝炎流行率估算中东和北非注射吸毒者中的艾滋病毒流行潜力。
AIDS. 2015 Aug 24;29(13):1701-10. doi: 10.1097/QAD.0000000000000761.
9
HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis.中东和北非地区注射吸毒者中的艾滋病毒:系统评价与数据综合
PLoS Med. 2014 Jun 17;11(6):e1001663. doi: 10.1371/journal.pmed.1001663. eCollection 2014 Jun.
10
Hepatitis C among Intravenous Drug Users in Isfahan, Iran: a Study of Seroprevalence and Risk Factors.伊朗伊斯法罕静脉吸毒者中的丙型肝炎:血清流行率及危险因素研究
Int J Prev Med. 2012 Mar;3(Suppl 1):S131-8.